7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Acromegaly D000172 6 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Actinomycosis D000196 2 associated lipids
Addison Disease D000224 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Angina, Unstable D000789 14 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Mogelvang R et al. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. 2012 Am. J. Cardiol. pmid:22100028
Chung E and Rylander MN Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. 2012 Cell Stress Chaperones pmid:22116637
Li J et al. Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. 2012 J Biomech pmid:22119108
Tanaka M et al. Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. 2012 Bone Marrow Transplant. pmid:22120987
Blázquez-Medela AM et al. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. 2012 Eur. J. Clin. Invest. pmid:22050177
Xu S et al. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. 2012 Rheumatol. Int. pmid:22057136
Ermakov S et al. A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. 2012 Osteoporos Int pmid:22057548
Zhao X et al. hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected]. 2012 J. Physiol. Biochem. pmid:22057889
Wang N et al. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. 2012 Mol. Endocrinol. pmid:22108801
Rojano-Mejía D et al. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. 2012 Maturitas pmid:22079369
Ueland T et al. TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. 2012 Curr Heart Fail Rep pmid:22453763
Bogliolo L et al. Biomarkers and prognostic stratification in psoriatic arthritis. 2012 Reumatismo pmid:22690385
Olesen M et al. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. 2012 Mol. Cell. Endocrinol. pmid:22698523
Cvija H et al. Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. 2012 Inflammation pmid:22699680
Liu L et al. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. 2012 J Endod pmid:22703658
Nakashima T et al. New insights into osteoclastogenic signaling mechanisms. 2012 Trends Endocrinol. Metab. pmid:22705116
Roodman GD Genes associate with abnormal bone cell activity in bone metastasis. 2012 Cancer Metastasis Rev. pmid:22706844
Martínez-Calatrava MJ et al. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. 2012 Arthritis Res. Ther. pmid:22709525
Kim H et al. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women. 2012 Menopause pmid:22668815
Duarte PM et al. Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. 2012 J. Periodontol. pmid:21859322
Ford ML et al. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. 2012 Nephrol. Dial. Transplant. pmid:21750158
Xie H et al. Omentin-1 exerts bone-sparing effect in ovariectomized mice. 2012 Osteoporos Int pmid:21755404
Chai YC et al. Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. 2012 Biomaterials pmid:22381474
Hudson JB et al. Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. 2012 Calcif. Tissue Int. pmid:22382900
Singh DK et al. Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. 2012 Diabetes Res. Clin. Pract. pmid:22386825
Jia P et al. The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. 2012 Eur. J. Pharmacol. pmid:22387856
Eleftheriadis T et al. Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. 2012 Iran J Kidney Dis pmid:22388612
Heymann MF et al. Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds. 2012 Cytokine pmid:22402034
Sun C et al. [Acqusition of full-length gene for rabbit osteoprotegerin]. 2012 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:22404020
Quan J et al. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. 2012 Pathology pmid:22406484
Yoon HY et al. Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro. 2012 J. Bone Miner. Metab. pmid:22407507
Wen Y et al. Application of eGFP to label human periodontal ligament stem cells in periodontal tissue engineering. 2012 Arch. Oral Biol. pmid:22410147
Vasconcelos AC et al. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation. 2012 J. Oral Pathol. Med. pmid:22417074
Renno AC et al. Ultrasound therapy modulates osteocalcin expression during bone repair in rats. 2012 Ultrasonics pmid:21820693
Bergström I et al. Physical training increases osteoprotegerin in postmenopausal women. 2012 J. Bone Miner. Metab. pmid:21823052
Zhang L et al. Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. 2012 Int Endod J pmid:21899569
Wang JQ et al. [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. 2012 Zhongguo Gu Shang pmid:23427595
Singh PP et al. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. 2012 Biochem. Biophys. Res. Commun. pmid:22561018
Aronis KN et al. Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults. 2012 J. Clin. Endocrinol. Metab. pmid:22563105
Djamiatun K et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. 2012 PLoS Negl Trop Dis pmid:22563509
Galli C et al. Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies. 2012 Acta Biomater pmid:22564787
Morena M et al. Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. 2012 PLoS ONE pmid:22567137
Banfi G et al. Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players. 2012 J Sports Med Phys Fitness pmid:22525657
Taddei SR et al. Role of CCR2 in orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22284282
Karieb S and Fox SW Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro. 2012 Br. J. Nutr. pmid:22289672
Lee JW et al. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. 2012 J Nat Med pmid:21656335
Larussa T et al. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. 2012 World J. Gastroenterol. pmid:22529691
Niu YB et al. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. 2012 Osteoporos Int pmid:22535190
Wieczorek-Baranowska A et al. Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks. 2012 Metab. Clin. Exp. pmid:22000586
Ostrowska Z et al. RANKL/RANK/OPG system and bone status in females with anorexia nervosa. 2012 Bone pmid:22001124
Kam WW et al. The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. 2012 PLoS ONE pmid:22295097
Martin CK et al. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. 2012 Oral Oncol. pmid:22265717
Reginster JY et al. Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. 2012 Bone pmid:22270053
Garlet GP et al. Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. 2012 J Endod pmid:22244633
Makras P et al. Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis. 2012 J. Clin. Endocrinol. Metab. pmid:22278426
Stępień E et al. Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects. 2012 Hypertens. Res. pmid:22278625
Babür C et al. Gingival crevicular fluid levels of osteoprotegerin (OPG) in premenopausal and postmenopausal women with or without chronic periodontitis. 2012 J Dent pmid:22326720
Bargman R et al. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. 2012 Pediatr. Res. pmid:22926546
Cauley JA Commentary: A single biomarker in a complex metabolic pathway. 2012 Int J Epidemiol pmid:22933649
Deuell KA et al. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. 2012 J. Vasc. Res. pmid:22948607
Li F et al. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. 2012 Fitoterapia pmid:22951288
Buckle CH et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. 2012 PLoS ONE pmid:22952578
Shen P et al. Expression of osteoprotegerin in placenta and its association with preeclampsia. 2012 PLoS ONE pmid:22952959
Diercke K et al. IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. 2012 J Orofac Orthop pmid:22955577
Chen YH et al. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. 2012 PLoS ONE pmid:22957004
Feng G et al. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women. 2012 J. Pediatr. Endocrinol. Metab. pmid:23329761
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Pereda GO et al. Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. 2012 Aust Dent J pmid:22924350
Zhao N et al. Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22196183
Chen J et al. OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. 2012 Rheumatol. Int. pmid:22210270
Giannopoulou C et al. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. 2012 Acta Odontol. Scand. pmid:22214279
Bloch SL and Sørensen MS Otosclerosis: a perilabyrinthine threshold phenomenon. 2012 Acta Otolaryngol. pmid:22217131
Wang S and Liu YS [Advance on arterial calcification]. 2012 Sheng Li Ke Xue Jin Zhan pmid:23189619
Rashtchizadeh N et al. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. 2012 Ther Apher Dial pmid:23190522
Pecchi E et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. 2012 Osteoarthr. Cartil. pmid:22179028
Xue Y et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. 2012 PLoS ONE pmid:23144698
Nicu EA et al. RCT comparing implants with turned and anodically oxidized surfaces: a pilot study, a 3-year follow-up. 2012 J. Clin. Periodontol. pmid:23151294
Adamczyk T et al. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. 2012 Pol. Arch. Med. Wewn. pmid:22237719
Ahmed HH et al. Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats. 2012 Eur Rev Med Pharmacol Sci pmid:23104664
Zhou YB et al. Insulin resistance induces medial artery calcification in fructose-fed rats. 2012 Exp. Biol. Med. (Maywood) pmid:22238287
Kwon SR et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. 2012 Rheumatol. Int. pmid:21833531
Nyrnes A et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. 2012 Gend Med pmid:23046763
Brandenburg V et al. Calcification inhibitors in vascular calciphylaxis associated with normal renal function. 2012 Thromb. Haemost. pmid:23092963
Ryser MD et al. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. 2012 PLoS Comput. Biol. pmid:23093918
Kleyer A et al. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. 2012 J. Bone Miner. Res. pmid:22806960
Giaginis C et al. Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. 2012 Med. Sci. Monit. pmid:23018352
Wang C et al. Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. 2012 J. Bone Miner. Res. pmid:22807154
Martínez E et al. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. 2012 AIDS pmid:23018438
Poerschke RL et al. Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. 2012 J. Biochem. Mol. Toxicol. pmid:22807314
Thadani U Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. 2012 Cardiology pmid:23018624
Chandran V Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. 2012 J Rheumatol Suppl pmid:22751596
Melchiorre D et al. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. 2012 J. Rheumatol. pmid:22753650
Rieder P et al. TiNOx coatings increase human primary osteoblasts proliferation independently of the substrate: a short report. 2012 Biomed Mater Eng pmid:23023144
Zhou W and Mei L Effect of autologous bone marrow stromal cells transduced with osteoprotegerin on periodontal bone regeneration in canine periodontal window defects. 2012 Int J Periodontics Restorative Dent pmid:22754911
Jansson AM et al. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23023373
Baud'huin M et al. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22761317
Taylan A et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. 2012 BMC Musculoskelet Disord pmid:23025387
Shen C et al. Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. 2012 Am. J. Cardiol. pmid:22762713
Luan X et al. Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. 2012 J. Immunol. pmid:22664871
Galli C et al. Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. 2012 Am J Orthod Dentofacial Orthop pmid:22640672

Table of Content